StockWatch
·
 Medicinal Chemicals and Botanical Products
Quarterly ResultMay 13, 2026, 04:42 PM

Upexi Q3 Revenue $4.6M; Net Loss $109.3M on digital asset losses

AI Summary

Upexi, Inc. announced its fiscal third quarter 2026 financial results, reporting total revenue of $4.6 million, a significant increase from $3.2 million in the prior year. Despite a 179% rise in gross profit to $4.4 million, the company posted a net loss of $109.3 million, or $1.67 per share, largely due to $92.3 million in unrealized losses on digital assets. Operationally, Upexi increased its Solana token holdings by 9%, repurchased approximately 2.5 million shares, and reduced short-term debt by $7.6 million, aligning with its digital asset treasury strategy.

Key Highlights

  • Total revenue for Q3 2026 was $4.6 million, up from $3.2 million year-over-year.
  • Gross profit totaled $4.4 million, a 179% increase year-over-year.
  • Net loss was $109.3 million, or $1.67 per share, primarily due to unrealized digital asset losses.
  • Unrealized losses on digital assets amounted to $92.3 million.
  • Solana tokens held in treasury increased by approximately 189,000, or 9%.
  • The company repurchased approximately 2.5 million Upexi shares in the open market.
  • Short-term debt was reduced by approximately $7.6 million.
  • Digital asset revenue for the quarter totaled $3.5 million.